(Q24246923)

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Hypericum treatment of mild depressions with somatic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Effects of hypericum extract on the sleep EEG in older volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St. John's wort has no effect on pain in polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St. John's Wort, an anti-depressant? A systematic, criteria-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St John's wort for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St. John's wort for depression: a meta-analysis of well-defined clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Atypical depression and related illnesses--neurobiological principles for their treatment with Hypericum extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Biologically active and other chemical constituents of the herb of Hypericum perforatum L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Explaining heterogeneity in meta-analysis: a comparison of methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Controlled clinical trials of hypericum extracts in depressed patients--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Placebo response in studies of major depression: variable, substantial, and growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Adverse Effects of St. John’s Wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Treatment of Seasonal Affective Disorder (SAD) with Hypericum Extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Cognitive Performance Test: A New Approach to Functional Assessment in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Second thoughts about safety of St John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

Effectiveness of St John's wort in major depression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Treatment of mild/moderate depressions with Hypericum

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum L

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

[St. John' Wort (Hypericum perforatum L.)--multicompound preparations versus single substances]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Effects of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Efficacy of continuation treatment with hypericum perforatum in depression.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021

Adverse effects of St. John's Wort: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB2

7 January 2021